Who are AmnioExCel dressing and compression therapy's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/amnioexcel-dressing-and-compression-therapy.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

AmnioExCel dressing and compression therapy — Competitive Intelligence Brief

AmnioExCel dressing and compression therapy (AmnioExCel dressing and compression therapy) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Biologic wound dressing. Area: Wound Care / Dermatology.

marketed Biologic wound dressing Wound Care / Dermatology Biologic Live · refreshed every 30 min

Target snapshot

AmnioExCel dressing and compression therapy (AmnioExCel dressing and compression therapy) — Prisma Health-Upstate. AmnioExCel is an amniotic membrane-derived wound dressing that promotes tissue healing and reduces inflammation when combined with compression therapy for chronic wounds.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
AmnioExCel dressing and compression therapy TARGET	AmnioExCel dressing and compression therapy	Prisma Health-Upstate	marketed	Biologic wound dressing

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Biologic wound dressing class)

Prisma Health-Upstate · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). AmnioExCel dressing and compression therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/amnioexcel-dressing-and-compression-therapy. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab